|
|
|
|
| LEADER |
02762nam a2200445 a 4500 |
| 001 |
EBC3340016 |
| 003 |
MiAaPQ |
| 005 |
20200520144314.0 |
| 006 |
m o d | |
| 007 |
cr cn||||||||| |
| 008 |
080305s2008 mau sb 001 0 eng |
| 010 |
|
|
|z 2008010541
|
| 020 |
|
|
|z 9780980209440 (hardcover : alk. paper)
|
| 020 |
|
|
|z 0980209447 (hardcover : alk. paper)
|
| 035 |
|
|
|a (MiAaPQ)EBC3340016
|
| 035 |
|
|
|a (Au-PeEL)EBL3340016
|
| 035 |
|
|
|a (CaPaEBR)ebr10233893
|
| 035 |
|
|
|a (CaONFJC)MIL172653
|
| 035 |
|
|
|a (OCoLC)923251603
|
| 040 |
|
|
|a MiAaPQ
|c MiAaPQ
|d MiAaPQ
|
| 050 |
|
4 |
|a HD9665.5
|b .I55 2008
|
| 082 |
0 |
4 |
|a 338.4/791510973
|2 22
|
| 245 |
0 |
0 |
|a Innovation and the pharmaceutical industry
|h [electronic resource] :
|b critical reflections on the virtues of profit /
|c edited by H. Tristram Engelhardt Jr. and Jeremy R. Garrett.
|
| 260 |
|
|
|a Salem, MA :
|b M & M Scrivener Press,
|c c2008.
|
| 300 |
|
|
|a viii, 245 p.
|
| 490 |
1 |
|
|a Trends and conflicts
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Pharmaceutical innovation and the market: the pursuit of profit and the amelioration of the human condition / H. Tristram Engelhardt Jr. & Jeremy R. Garrett -- The unavoidable goodness of profit: the cunning of reason and the realization of human well-being / H. Tristram Engelhardt Jr -- Corporate social responsibility and business ethics in the pharmaceutical industry / Nicholas Capaldi -- Pharmaceutical companies: psychopaths or scapegoats / Pepe Lee Chang -- Autonomy, constraining options, and pharmaceutical costs / James Stacy Taylor -- Pharmaceutical advertising and patient autonomy / Andrew I. Cohen -- Does America have a second drug problem? / Richard A. Epstein -- Global drug innovation in a world of financial finitude: retailing virtue to promote -- Capital formation and profit / Michael A. Rie -- Time, money, and the market for drugs / John C. Goodman -- Perils of parallel trade: reimporting prescription drugs from Canada to the U.S. / John R. Graham -- Risk, responsibility, and litigation / Sandra H. Johnson & Ana Smith Iltis.
|
| 533 |
|
|
|a Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
|
| 650 |
|
0 |
|a Pharmaceutical industry.
|
| 650 |
|
0 |
|a Drug development.
|
| 650 |
|
0 |
|a Medical innovations.
|
| 650 |
|
0 |
|a Medical policy
|z United States.
|
| 650 |
|
0 |
|a Drugs
|x economics
|z United States.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Engelhardt, H. Tristram
|q (Hugo Tristram),
|d 1941-
|
| 700 |
1 |
|
|a Garrett, Jeremy R.
|
| 710 |
2 |
|
|a ProQuest (Firm)
|
| 830 |
|
0 |
|a Conflicts and trends.
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/matrademy/detail.action?docID=3340016
|z Click to View
|
